USPTO serial 78359972
CANCERGENIE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- MILTON, PRISCILLA
- Law office
- TMO LAW OFFICE 110 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with CANCERGENIE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
F. Andrew Anderson
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | computer software, optical disc media, and other electronic media providing gene expression profile information for use in predicting cancer, selecting therapeutics, evaluating efficacy and toxicity of treatments, and evaluating treatment programs; diagnostic devices for selecting therapeutics, evaluating efficacy and toxicity of a therapeutic treatment regime, and evaluating treatment of cancer; point-of-care equipment for carrying out and/or evaluation of medical-diagnostic examinations related to cancer; diagnostic devices for clinical, laboratory, or medical use to diagnose, prognose, predict or evaluate cancer ; computer software, optical disc media, and other electronic media providing gene expression profile information for use in predicting cancer, selecting therapeutics, evaluating efficacy and toxicity of treatments, and evaluating treatment programs; diagnostic devices for selecting therapeutics, evaluating efficacy and toxicity of a therapeutic treatment regime, and evaluating treatment of cancer; point-of-care equipment for carrying out and/or evaluation of medical-diagnostic examinations related to cancer; diagnostic devices for clinical, laboratory, or medical use to diagnose, prognose, predict or evaluate cancer | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 18, 2005 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 17, 2005 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Sep 7, 2004 | EMRV | EMAIL RECEIVED | — |
| Sep 4, 2004 | UNPR | UNRESPONSIVE/DUPLICATE PAPER RECEIVED | — |
| Sep 4, 2004 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 4, 2004 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 23, 2004 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 10, 2004 | NWAP | NEW APPLICATION ENTERED | — |